These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14645406)

  • 21. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells.
    Noh EJ; Jang ER; Jeong G; Lee YM; Min CK; Lee JS
    Cancer Res; 2005 Dec; 65(24):11400-10. PubMed ID: 16357148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of inhibiting the lymph node metastasis in human gastric carcinoma by B7-1 gene transfection.
    Sakate Y; Yashiro M; Tanaka H; Sunami T; Kosaka K; Hirakawa K
    J Surg Res; 2004 Nov; 122(1):89-95. PubMed ID: 15522320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
    Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
    Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
    Fukamachi H
    Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
    So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
    Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas.
    Carvalho R; Milne AN; Polak M; Corver WE; Offerhaus GJ; Weterman MA
    Oncogene; 2005 Dec; 24(56):8252-8. PubMed ID: 16091737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
    Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
    Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
    Osaki M; Moriyama M; Adachi K; Nakada C; Takeda A; Inoue Y; Adachi H; Sato K; Oshimura M; Ito H
    Eur J Clin Invest; 2004 Sep; 34(9):605-12. PubMed ID: 15379759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
    J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity.
    Wang YW; Qu Y; Li JF; Chen XH; Liu BY; Gu QL; Zhu ZG
    Clin Cancer Res; 2006 Aug; 12(16):4965-73. PubMed ID: 16914586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal locoregional treatment in gastric cancer.
    Jansen EP; Boot H; Verheij M; van de Velde CJ
    J Clin Oncol; 2005 Jul; 23(20):4509-17. PubMed ID: 16002841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S
    Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
    Wu CS; Chen MF; Lee IL; Tung SY
    J Clin Gastroenterol; 2007; 41(10):894-900. PubMed ID: 18090157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
    Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node mapping with GI cancer.
    Aikou T; Kitagawa Y; Kitajima M; Uenosono Y; Bilchik AJ; Martinez SR; Saha S
    Cancer Metastasis Rev; 2006 Jun; 25(2):269-77. PubMed ID: 16770539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.
    Vogiatzi P; Vindigni C; Roviello F; Renieri A; Giordano A
    J Cell Physiol; 2007 May; 211(2):287-95. PubMed ID: 17238139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sixth annual ECP (European Organization for Cooperation in Cancer Prevention Studies) symposium. International symposium on gastric carcinogenesis. London, March 7-8, 1988. Abstracts.
    Cancer Lett; 1988 Mar; 39 Suppl 1():S1-45. PubMed ID: 3345511
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic guideline reviews. Stomach cancer--the Japanese Society of Stomach Cancer].
    Yoshida S
    Nihon Naika Gakkai Zasshi; 2002 Feb; 91(2):674-84. PubMed ID: 11917491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.